🇺🇸 FDA
Patent

US 8986737

Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth

granted A61KA61K9/0024A61K9/1647

Quick answer

US patent 8986737 (Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth) held by The Board of Regents of the University of Texas System expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K9/0024, A61K9/1647, A61P, A61P31/00